Actively Recruiting
BOdygUardian Monitoring for Recurrence of Atrial Fibrillation BOUNCE-AF Observational Registry
Led by Heart Rhythm Clinical and Research Solutions, LLC · Updated on 2026-10-28
100
Participants Needed
5
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
The DISRUPT-AF Registry is an observational, prospective, multi-center study designed to collect real-world clinical data on the FARAPULSE Pulsed Field Ablation PFA System for treating atrial fibrillation AF. This study specifically focuses on a subset of patients from the DISRUPT AF Registry who participate in the BOUNCE-AF sub-study. The purpose is to gather experience and monitor outcomes after ablation treatment for AF. Participants in the BOUNCE-AF sub-study will wear the BodyGuardian device for monitoring at 6 months post-ablation, following the sites standard of care which typically includes monitoring at 6 and 12 months after the procedure. Both patients and clinical staff involved with the BodyGuardian device will be asked to complete surveys about their experience with the monitoring device. During the study, patients will be observed based on their routine care schedules, with data on BodyGuardian wear collected at 6 months. Clinical staff who consent will also provide feedback through surveys. The primary outcome is measured from enrollment until the end of BodyGuardian wear at 6 months. The total participation duration extends through the monitoring period, with follow-up assessments aligned to clinical practice.
CONDITIONS
Brief Title
BOdygUardian MOnitoriNg for ReCurrencE of AF
Research Team
K
Kayla Oliver
M
Megan Goodfellow
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here